Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05727176
Title Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement (FOENIX-CCA4)
Acronym FOENIX-CCA4
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | ESP | AUS

Additional content available in CKB BOOST